News / Taiwan / economic_daily
Grape King Bio October Revenue Dips on High Base Effect, Shanghai Unit Surges
Consumer Non-Durables · Food: Specialty/Candy · economic_daily · 2026-11-09
1707
Grape King Bio reported a year-on-year decline in October revenue due to a high comparison base, though its Shanghai operations saw strong double-digit growth.
What Happened
Revenue Overview: Grape King Bio reported October consolidated revenue of NT$748 million, a 30.77% year-on-year decline, with cumulative ten-month revenue down 8.9%. The company attributed this drop to a high base effect from strong OEM orders and direct sales promotions during the same period last year.
Shanghai Operations: The Shanghai unit demonstrated robust performance, with October revenue rising 33.29% and cumulative ten-month revenue growing 14.03%. Collaborative functional beverage products with Hema Fresh have become market hits, and the company is expanding its AI-powered vending machine network.
International Expansion: Operations in Malaysia have shown steady growth since August, with increasing membership and sales momentum. The company is also upgrading its OEM/ODM business model, moving toward collaborative R&D with international partners, supported by recent global industry awards.
Future Outlook: Despite temporary headwinds in the domestic direct sales and brand segments, core products like the CombeT and probiotic series remain strong. The company is currently focusing on year-end shopping festivals and long-term international market development to sustain its growth trajectory.